Clinical trial

BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)

NCT00523328

Study summary

ClinicalTrials.gov

BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention BG9924 Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2007-08-01

PhasePHASE2

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

BG9924DRUG

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

TorontoOntario, Canada1 Palo AltoCalifornia, United States1 LiègeBelgium1 NewcastleUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00523328 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.